英菲格拉替尼进医保了吗,药物不良反应是什么?

Cholangiocarcinoma, a cancer of the bile ducts in the liver, is a serious and often fatal disease. The oral, ATP-competitive, FGFR tyrosine kinase inhibitor, also called Infigratinib, Truseltiq, is indicated for the treatment of previously treated patients with locally advanced or metastatic cholangiocarcinoma (CCA) harboring FGFR2 fusions or rearrangements. So, is Infigratinib included in medical insurance, and what are the adverse drug reactions?

Is Infigratinib included in medical insurance?

Infigratinib was approved for marketing by the U.S. FDA in May 2021. There is currently no data showing the domestic marketing of the drug, let alone medical insurance. Patients need to pay for it when purchasing it abroad, which imposes a heavy financial burden. Patients can also learn about Infigratinib, which is available overseas, through Medical Companion Travel. It is affordable and guaranteed to be authentic, which can reduce a considerable financial burden. It is recommended to consult the Medical Companion Travel service staff for specific costs and drug purchase procedures.

what is

Infigratinib has a significant therapeutic effect and can improve the quality of life of patients. Common adverse reactions include nail toxicity, stomatitis, alopecia, palmoplantar erythema sensory syndrome, dry eye syndrome, fatigue, joint pain, dysgeusia, diarrhea, dry skin, constipation, dry mouth, eyelash changes, loss of appetite, blurred vision, abdominal pain, vomiting, etc. Patients' constitutions and conditions are different, and the manifestations of adverse reactions are also different.

Infigratinib blocks downstream signaling cascades by selectively binding and inhibiting FGFR activity, reducing cancer cell proliferation and inducing tumor cell death. Patients must follow the doctor's instructions and cannot use it indiscriminately. The above is the content of whether Infigratinib is included in medical insurance and what adverse drug reactions are. I hope it can help you!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: